Human Health Holdings Ltd.

As of December 31, 2025, Human Health Holdings Ltd. carries a market capitalization of 299.85M, placing it among publicly traded companies globally. Its enterprise value stands at -54.65M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of December 31, 2025, Human Health Holdings Ltd. has 379.55M shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, Human Health Holdings Ltd. maintains a current ratio of 3.14, meaning it holds 3.1x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on October 22, 2026, Human Health Holdings Ltd.'s stock has declined approximately 11.63% over the past 52 weeks. The 50-day moving average sits at 0.75, while the 200-day moving average is 0.82.

As of December 31, 2025, Human Health Holdings Ltd. holds 474.53M in cash and equivalents against 120.03M in total debt, resulting in a net debt position of -458.44M. Total book value stands at 786.26M, with working capital of 414.71M providing operational flexibility.